Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glaxo, Sanofi Look Far Afield For Consumer Health Growth

Executive Summary

Big pharmas' recent third-quarter results and commentaries point to sales drivers for consumer health divisions coming from markets outside their established primary markets of US and Europe. Consumer unit lines include oral care and topicals as well as nutritional products.

Advertisement

Related Content

GSK Invests In OTC Production, Prepares To Divest Horlicks Nutritional Business
Bayer’s Consumer Health Sales Stay Cool During Summer Months
Pfizer Deals Consumer Health Its Own Hand, Plays Waiting Game For Bids
Glaxo Opts For Solo Navigation To Boost Control In Consumer Health Market
GSK And Reckitt Opting Out Of Pfizer's Consumer Business Sale Speaks Volumes
GSK Rides Cold, Flu And Pain OTCs In Q4 While Allergy Carries Sanofi

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124216

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel